These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 8019766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ, ter Laak MP, Kamal A, Gispen WH.
    Brain Res; 2005 Feb 21; 1035(1):86-93. PubMed ID: 15713280
    [Abstract] [Full Text] [Related]

  • 6. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
    Zhang W, Kamiya H, Ekberg K, Wahren J, Sima AA.
    Diabetes Metab Res Rev; 2007 Jan 21; 23(1):63-70. PubMed ID: 16845685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
    Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G.
    Diabetologia; 2001 Jul 21; 44(7):889-97. PubMed ID: 11508275
    [Abstract] [Full Text] [Related]

  • 12. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
    Cameron NE, Cotter MA, Dines KC, Robertson S, Cox D.
    Br J Pharmacol; 1993 Aug 21; 109(4):972-9. PubMed ID: 8401950
    [Abstract] [Full Text] [Related]

  • 13. Presynaptic deficit of sympathetic nerves: a cause for disturbed sciatic nerve blood flow responsiveness in diabetic rats.
    Van Buren T, Kasbergen CM, Gispen WH, De Wildt DJ.
    Eur J Pharmacol; 1996 Feb 05; 296(3):277-83. PubMed ID: 8904079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide.
    Sima AA, Zhang W, Li ZG, Murakawa Y, Pierson CR.
    Diabetes; 2004 Jun 05; 53(6):1556-63. PubMed ID: 15161761
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F, Szabó C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, Obrosova IG.
    Diabetologia; 2004 Apr 05; 47(4):710-7. PubMed ID: 15298348
    [Abstract] [Full Text] [Related]

  • 18. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
    Cameron NE, Dines KC, Cotter MA.
    Diabetologia; 1994 Dec 05; 37(12):1209-15. PubMed ID: 7895950
    [Abstract] [Full Text] [Related]

  • 19. Dorsal root ganglia microenvironment of female BB Wistar diabetic rats with mild neuropathy.
    Zochodne DW, Ho LT, Allison JA.
    J Neurol Sci; 1994 Dec 01; 127(1):36-42. PubMed ID: 7699389
    [Abstract] [Full Text] [Related]

  • 20. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
    Cotter MA, Dines KC, Cameron NE.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May 01; 347(5):534-40. PubMed ID: 7686634
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.